top of page

STI Directory Leader

ten23 health AG


ten23 health is a pharmaceutical CDMO (contract development and manufacturing organization). We offer solutions for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow’s medicines. We support our clients in developing differentiated, stable, usable, and safe injectable treatments for patients.

Jahr der Aufnahme



Pharmaceuticals & Supplies






Direkter Beitrag zu den SDGs


Goal 1

By 2025, we remove twice as much plastic from the environment than we send to final disposal*.

* On an annual basis, by combining measures of reduction, substitution, recycling, and plastic-offsetting (removing existing plastic from the oceans with partner organizations). Final disposal means incineration or landfill.

Core business

Goal 2

By 2025, we reduce our greenhouse gas emissions by 50 % (Scopes 1 & 2), and commit to the Science Based Targets initiative (SBTi)*.

* On a 2021 basis, pro rata to the months of activity in the year.

Internal operations

Goal 3

By 2023, we achieve equal treatment of all employees in the workspace, ensuring no gender pay gap*.

* Carried out by third-party assessment.

Internal operations

Goal 4

By 2023, we promote diversity in the workspace by targeting minimum 50% non-cis-male employees and obtaining the Swiss LGBTI label certification*.

* Carried out by third-party assessment.

Internal operations

ten23 health operates in Switzerland through several subsidiaries. The company is represented by ten23 health AG in Basel and Swissfillon AG in Visp. The pledges taken within the STI framework relate to the fairstainability policy applying to all ten23 health operations carried out in Switzerland. The company is therefore accountable for their implementation within the limits of its scope of activity.

Hinweis: Bis 2023 bezeichnet systematisch das Ende des Jahres, das heisst: Bis zum Ende des Jahres 2023 (ausser anders definiert, z. B. Geschäftsjahr)

Other Commitments

bottom of page